Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
--------
Question: The council, which covers the city's business center, was "reviewing (its) weed management methods and investigating other technologies", a spokeswoman told Reuters in an email, a day after a strike by workers at a nearby council pressured it into trialing an alternative weedkiller. The City of Sydney council currently used Roundup "as a last resort ... when non-pesticide methods such as hand-weeding and mulching have been ineffective", and began testing alternative products in late 2018, the spokeswoman added. Bayer says Roundup is safe and backed by several regulatory bodies, despite research that found its main ingredient glyphosate was probably carcinogenic. The German company has been hit by massive compensation payouts in the United States this year, over claims its product caused cancer, which have seen its shareprice to plummet. The prospect of Sydney council rethinking its ties to Roundup, a flagship product of U.S. agribusiness giant Monsanto Co until a buyout from Bayer last year, shows the pressure that grassroots campaigns and lawsuits are putting on governments about the product even as regulators declare it safe. "Because there's a lot of emotion around it, local agencies may be moved to make a decision that's made based on placating the general public rather than the available science," said Ian Musgrave, a molecular pharmacologist and toxicologist at University of Adelaide. "We should be making decisions on safety based on actual science, not based on our fear or dismay of megacorporations." Earlier this week, Blacktown City Council in Sydney's west agreed to trial an alternative to Roundup after a worker strike over the product left 40,000 garbage bins unemptied. Another four councils around Sydney previously quit using Roundup over possible links to cancer. Last month, an Australian gardener filed the country's first lawsuit against Bayer, accusing Monsanto of causing him harm from exposure to glyphosate via decades of using Roundup. A Bayer spokesman said the company "encourages constructive dialogue with our stakeholders to build a broader trust in science". The company had published "extensive research which supports our products' safety" and was "committed to ensuring our customers continue to have access to these critical products as part of their sustainable agricultural activities".

Answer: Sydney's city council reviews use of Bayer's Roundup weed killer amid cancer fears.

Question: The outbreak comes ahead of the Lunar New Year holiday in late January, when many of China's 1.4 billion people will be travelling to their home towns or abroad. The World Health Organization and Chinese authorities are taking steps to ensure the disease does not spread further. Thai health authorities said on Wednesday they were stepping up monitoring of passengers arriving at airports with infrared thermal scanners ahead of the holiday, when 800,000 Chinese tourists are expected to visit the country. Memories remain fresh in Asia of a 2002-2003 outbreak of SARS, or Severe Acute Respiratory Syndrome (SARS), which emerged in China and killed nearly 800 people worldwide. WHO has said there may have been limited human-to-human transmission of the new coronavirus in China within families. And authorities in Wuhan confirmed on Wednesday that a married couple were among 41 people diagnosed with pneumonia believed to be caused by the new virus. There were no new cases or deaths at the end of Tuesday, the city's health authority said. The Wuhan Municipal Health Commission did not say in the statement whether the couple represented an instance of human-to-human transmission. But it said the husband, who worked at a seafood market suspected of being at the epicentre of the outbreak, was the first to fall ill and that his wife did not have any exposure to the market. Some of the other people diagnosed also denied visiting the market, the commission said. The authorities in Wuhan also confirmed that a Chinese woman quarantined in Thailand, the first case of the mystery strain of coronavirus to be detected outside of China, had come from Wuhan. The State Department's notice referred to an alert by the U.S. Centers for Disease Control and Prevention urging citizens in China travelling to Wuhan to avoid contact with animals, animal markets or animal products, among other precautions. It also asked citizens those who had visited Wuhan and feel sick to seek medical care. The Wuhan health commission said in another statement issued late Wednesday that 7 of the 41 pneumonia patients have been released. The statement also said that 450 of the 763 people put under observation due to their close contact with known patients have been released.

Answer: U.S. warns citizens in China about pneumonia outbreak.

Question: It's good that the report states the price of the deviceabove $200,000and that at least one insurer does not pay for its use. But the story should have stated what it costs a patient to get treated with the device, and who bears any additional costs. The story says the device's efficacy is uNPRoven, but it does not explore the body of inconclusive data. There is a 2007 study that shows 5 years of outcome data. The fact that that study did not demonstrate improved outcomes suggests the device does not have big, measurable benefits. The story would have been stronger had it referred to this study. The story reports that the extra time required to do a navigation-assisted surgery may lead to more complications. The story would have been stronger if it had mentioned the potential risks associated with the surgeon learning curve. The story does an excellent job of stating, plainly and repeatedly, that there is no conclusive evidence the surgical device improves outcomes. The story doesn't exaggerate the severity or prevalence of the underlying joint conditions. Neither does it make false claims for the relief the device can provide. The story does use one positive anecdote, which could be read to mean the navigational device contributed to the positive outcome. The reality is that most patients do very well with the surgery without the need for a navigational prompt to the surgeon.But since the story states repeatedly that the technology's benefits are uNPRoven, this is not a serious flaw. The reporter interviewed four surgeons, three of whom use the device and one of whom does not. The reporter did not quote the device maker, an impressive show of restraint. A key shortcoming: The reporter did not explore potential conflicts of interest of the sources. Doctors who are early adopters of expensive new technologies often have relationships with the device makers. So do the medical facilities where the doctors practice. Such relationships should have been disclosed, or the lack of relationship should have been plainly stated. The story indicates that most surgeries are done without the navigation device, and that other similar devices are in development. The story names four Iowa institutions that have the computer assisted surgery device. It also names four surgeons who use it. Ideally the story would stated how many of the devices are in use in Iowa, Des Moines or the U.S. But the story includes sufficient information to be rated satisfactory under this criterion. The report makes clear that the device has been in use for a few years but is still considered investigational. By reporting how many surgeries certain centers and surgeons have done with the device, the story provides an adequate view of its clinical use. There is no evidence that the story relied solely or largely on a news release.

Answer:
GPS-like system helps surgeons align joints